yutaka niihara  cofounder at emmaus medical inc news home advertising board and executive moves energy health care hedge funds m  a private equity technology you have    free profiles   left this month    start your free trial ➤ hey we noticed youre a relsci pro subscriber would you like to view the page there view on relsci pro ➤ email linkedin facebook google tweet reddit permalink yutaka niihara cofounder at emmaus medical inc overview in the news relationships paths education memberships career history boards  committees investments transactions yutaka niihara cofounder at emmaus medical inc overview age  born  notable companies emmaus life sciences inc hope international hospice inc newfield nutrition corp board seats  number of relationships this person is connected to  people in the news see more pr newswire july   the us food  drug administration approves endaritm lglutamine oral powder the first and only treatment for sickle cell disease in pediatric patients and first in nearly  years for adults pr newswire may   fda advisory committee recommends approval of endaritm from emmaus life sciences for the treatment of sickle cell disease pr newswire april   emmaus life sciences inc announces fda advisory committee meeting for endaritm for sickle cell disease pr newswire march   emmaus life sciences inc to present at los angeles biomedical research institutes la biomed innovation showcase business wire february   generex provides update on deal to acquire controlling equity interest in emmaus life sciences inc see full news coverage and complete stories with relsci professional create your news feed see more relationships see details willis c lee chief financial officer  director at emmaus medical inc henry a mckinnell chairman emeritus at connecticut science center inc lan t tran copresident at emmaus life sciences inc tracey c doi treasurer at trd usa inc peter b ludlum executive vice president  chief financial officer at emmaus medical inc maurice j dewald founder at verity financial group inc moni miyashita former vice president at international business machines corporation jinhoon im chief executive officer  president at telcon inc s steven lee independent consultant at emmaus life sciences inc jon kuwahara senior vice president of finance  administration at novus therapeutics inc see  more listings with relsci professional start my free trial ➤ see  more paths to yutaka niihara yutaka niihara you connections via relationship science yutaka niihara sync your contacts to see how you can connect with yutaka niihara start my free trial ➤ see more educational background   class of   loma linda university  school of medicine doctorate degree  class of   loma linda university educating ethical and proficient christian health professionals and scholars through instruction example and the pursuit of truthexpanding knowledge through research in the biological behavioral physical and environmental sciences and applying this knowledge to health and disease providing comprehensive competent and compassionate health care for the whole person through faculty students and alumni memberships member current usjapan council the usjapan council is an organization dedicated to strengthening ties between the united states and japan in a global context by promoting peopletopeople relationships through its innovative programs in networking and leadership the usjc serves as a catalyst to inspire and engage japanese and americans of all generations led by japanese americans usjc develops the next generation of leaders committed to a vibrant and dynamic relationship career history chief executive officer   current emmaus life sciences inc emmaus life sciences inc discovers develops and commercializes treatments and therapies for rare diseases the firm also engages in the marketing and sale of nutrestore lglutamine powder for oral solution a treatment for short bowel syndrome and the sale of lglutamine as a nutritional supplement under the brand name aminopure the company was founded by yutaka niihara and is headquartered in torrance ca president chief executive officer  medical director   current hope international hospice inc hope international hospice inc provides services across languageethnic patient groups residing within the geographical boundaries of los angeles county and parts of orange county its services include medical expertise nursing care personal care of bathing grooming and activities of daily living the company is headquartered in torrance ca cofounder   current emmaus medical inc emmaus medical inc engages in the discovery development and commercialization of treatments and therapies for rare diseases its current business is the latestage development presently in phase iii clinical trials with the fda of the amino acid lglutamine as a prescription drug for the treatment of sickle cell disease the company was founded on december   and is headquartered in torrance ca faculty member medical oncology  hematology current los angeles biomedical research institute at harborucla medical center to engage in biomedical research educate and provide community health services president chief executive officer  director prior newfield nutrition corp clinical professor of medicine division of medical oncologyhematology prior university of california los angeles  david geffen school of medicine the university of california los angeles school of medicine known as the david geffen school of medicine at ucla is an accredited medical school located in los angeles california usa boards  committees corporate boards ▾ chairman  chief executive officer   current emmaus life sciences inc emmaus life sciences inc discovers develops and commercializes treatments and therapies for rare diseases the firm also engages in the marketing and sale of nutrestore lglutamine powder for oral solution a treatment for short bowel syndrome and the sale of lglutamine as a nutritional supplement under the brand name aminopure the company was founded by yutaka niihara and is headquartered in torrance ca director chief executive  financial officer   current hope international hospice inc hope international hospice inc provides services across languageethnic patient groups residing within the geographical boundaries of los angeles county and parts of orange county its services include medical expertise nursing care personal care of bathing grooming and activities of daily living the company is headquartered in torrance ca director   current emmaus medical inc emmaus medical inc engages in the discovery development and commercialization of treatments and therapies for rare diseases its current business is the latestage development presently in phase iii clinical trials with the fda of the amino acid lglutamine as a prescription drug for the treatment of sickle cell disease the company was founded on december   and is headquartered in torrance ca director current telcon inc telcon inc manufactures develops and supplies cables and connectors its products include rf coaxial connector cable assembly coaxial coupler coaxial distributor and coaxial arrester the company was founded on january   and is headquartered in hwaseong south korea director current emmaus medical europe ltd director current emausu medical japan co ltd executive chairman    generex biotechnology corp generex biotechnology corp engages in the research development and commercialization of drug delivery systems and technologies the company focuses on proprietary technology for the administration of formulations of large molecule drugs to the oral cavity using a handheld aerosol applicator its product orallyn is an insulin spray formulation used for the treatment of type and type diabetes generex biotechnology was founded by anna e gluskin and rose c perri in september  and is headquartered in burlington canada president chief executive officer  director prior newfield nutrition corp investments details hidden emmaus medical inc emmaus medical inc engages in the discovery development and commercialization of treatments and therapies for rare diseases its current business is the latestage development presently in phase iii clinical trials with the fda of the amino acid lglutamine as a prescription drug for the treatment of sickle cell disease the company was founded on december   and is headquartered in torrance ca transactions details hidden emmaus life sciences inc raised money in a private placement transaction details hidden emmaus life sciences inc raised money in a private placement transaction details hidden emmaus life sciences inc raised money in a private placement transaction details hidden emmaus life sciences inc raised money in a private placement transaction details hidden emmaus life sciences inc raised money in a private placement transaction see  more listing with relsci professional start my free trial ➤ see  more other affiliations yutaka niihara is affiliated with emmaus life sciences inc hope international hospice inc emmaus medical inc los angeles biomedical research institute at harborucla medical center newfield nutrition corp university of california los angeles  david geffen school of medicine emmaus life sciences inc hope international hospice inc emmaus medical inc telcon inc emmaus medical europe ltd emausu medical japan co ltd generex biotechnology corp newfield nutrition corp youve reached your  free profiles limit this month upgrade to relsci pro today to enjoy unlimited article views and much more start my free trial ➤ still not convinced check out our full listing of features here are you a relsci pro subscriber login to relsci pro  ➤ not a pro subscriber log in here to manage your alerts keep me signed in login  ➤ forgot your password i have read the lexisnexis terms  conditions sign me up  ➤ yutaka niihara md mph ceo of emmaus appointed executive chairman of generex biotechnology yutaka niihara md mph ceo of emmaus appointed executive chairman of generex biotechnology corporation news provided by emmaus life sciences jan    et share this article torrance calif jan   prnewswire  emmaus announced today that its chairman and chief executive officer yutaka niihara md mph has joined the board of directors of generex biotechnology corporation generex otcpink gnbt as executive chairman this follows the prior announcement that emmaus entered into a letter of intent on a collaborative agreement with generex emmaus filed a form k current report in respect of the agreement with the us securities and exchange commission on january    emmaus is also an sec registrant its filings including audited financial information are publicly available at wwwsecgov generex is working toward rebuilding its company with a plan toward uplisting to a major stock exchange emmaus is working toward achieving approval and commercialization of its treatment for sickle cell disease joseph moscato generex president  chief executive officer stated we welcome dr niihara and look forward to his contributions to our joint efforts to advance both generex and emmaus technologies  this is another symbol of how emmaus and generex will collaborate on the synergistic growth of generex and emmaus commented dr yutaka niihara md mph emmaus chief executive officer i look forward to working closely with the team at generex about emmaus life sciencesemmaus life sciences is engaged in the discovery development and commercialization of innovative treatments and therapies for rare diseases the companys research on sickle cell disease was initiated by yutaka niihara md mph chairman and ceo of emmaus at the los angeles biomedical research institute at harborucla medical center for more information please visit wwwemmauslifesciencescom forwardlooking statements this press release contains forwardlooking statements as that term is defined in the private securities litigation reform act of  regarding the research development and potential commercialization of pharmaceutical products such forwardlooking statements are based on current expectations and involve inherent risks and uncertainties including factors that could delay divert or change any of them and could cause actual outcomes and results to differ materially from current expectations additional risks and uncertainties are described in reports filed by emmaus life sciences inc with the us securities and exchange commission including its annual report on form k and quarterly reports on form q emmaus is providing this information as of the date of this press release and does not undertake any obligation to update any forwardlooking statements as a result of new information future events or otherwise for more information contact media jim heinssenior vice presidenticr healthcarejamesheinsicrinccom investors charles butlersenior vice presidenticr healthcarecharlesbutlericrinccom   to view the original version on pr newswire visithttpwwwprnewswirecomnewsreleasesyutakaniiharamdmphceoofemmausappointedexecutivechairmanofgenerexbiotechnologycorporationhtml source emmaus life sciences related links httpwwwemmauslscom apr    et preview emmaus life sciences inc announces fda advisory committee meeting for endari™ for sickle cell disease dec    et preview emmaus life sciences inc receives japanese patent for use of lglutamine in treatment of diverticulosis my news release contains wide tables view fullscreen also from this source apr    et emmaus life sciences inc announces fda advisory committee explore more news releases in similar topics biotechnology health care  hospitals medical pharmaceuticals personnel announcements you just read yutaka niihara md mph ceo of emmaus appointed executive chairman of generex biotechnology corporation news provided by emmaus life sciences jan    et share this article looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search emmaus life sciences announces reappointment of dr yutaka niihara as ceo emmaus life sciences announces reappointment of dr yutaka niihara as ceo continues to lead efforts to advance sickle cell disease treatment jan    et from emmaus life sciences inc torrance calif jan   prnewswire  emmaus life sciences inc the company or emmaus a biopharmaceutical company engaged in the discovery development and commercialization of innovative treatments and therapies for rare and orphan diseases announced the recent reappointment of yutaka niihara md mph the companys cofounder and chairman as ceo of the company niihara will continue to lead the work on emmaus pharmaceutical grade lglutamine treatment pglg having completed its phase  trial for the management of sickle cell disease scd   we started  with renewed focus continuing to advance our work on our sickle cell program said niihara in  we raised over  million with the support of loyal shareholders to bring our total funds raised to more than  million i would like to thank our loyal shareholders now in excess of  and express gratitude to our management team and new board members as we move forward niihara is the principal inventor of the patented lglutamine therapy for treatment of sickle cell disease has been involved in patient care and research for sickle cell disease during most of his career and is a widely published author in the area of sickle cell disease dr niihara is boardcertified by the american board of internal medicinemedical oncology and the american board of internal medicinehematology he is licensed to practice medicine in both the us and japan dr niihara is a professor of medicine at the david geffen school of medicine at ucla he received his ba in religion from loma linda university in  and obtained his md degree from the loma linda university school of medicine in  and received his mph from harvard school of public health in  about emmaus life sciencesemmaus life sciences is engaged in the discovery development and commercialization of innovative treatments and therapies for rare diseases the companys research on scd was initiated by dr niihara at the los angeles biomedical research institute at harborucla medical center emmaus scd therapy has orphan drug designation in the us and europe and fast track designation from the fda the company has completed a  patient phase  trial for more information please visit wwwemmauslifesciencescom about sickle cell diseasescd is an inherited blood disorder characterized by the production of an altered form of hemoglobin which polymerizes and becomes fıbrous causing red blood cells to become rigid and change form so that they appear sickle shaped instead of soft and rounded patients with scd suffer from debilitating episodes of sickle cell crisis which occur when the rigid adhesive and inflexible red blood cells occlude blood vessels sickle cell crisis causes excruciating pain as a result of insufficient oxygen being delivered to tissue referred to as tissue ischemia and inflammation these events may lead to organ damage stroke pulmonary complications skin ulceration infection and a variety of other adverse outcomes scd is an orphan disease in the us affecting approximately  patients in the us and millions worldwide with significant unmet medical needs forwardlooking statementsthis press release contains forwardlooking statements as that term is defined in the private securities litigation reform act of  regarding the research development and potential commercialization of pharmaceutical products such forwardlooking statements are based on current expectations and involve inherent risks and uncertainties including factors that could delay divert or change any of them and could cause actual outcomes and results to differ materially from current expectations additional risks and uncertainties are described in reports filed by emmaus life sciences inc with the us securities and exchange commission including its annual report on form k and quarterly reports on form q emmaus is providing this information as of the date of this press release and does not undertake any obligation to update any forwardlooking statements as a result of new information future events or otherwise contactsmedialori teranishi lteranishiiqinccom  investorsmatt sheldon msheldonpondelcom   source emmaus life sciences inc related links httpwwwemmauslifesciencescom view table fullscreen view table fullscreen journalists and bloggers the news you need when you need it join pr newswire for journalists to access all of the free services designated to make your job easier in need of subject matter experts for your story submit a free profnet request and find the sources you need learn more jan    et preview emmaus life sciences secures funding to advance sickle cell disease treatment dec    et preview emmaus life sciences appoints durbin as distribution partner my news release contains wide tables view fullscreen read more feb    et emmaus life sciences inc to present at los angeles biomedical feb    et emmaus life sciences inc receives notice of allowance for feb    et emmaus life sciences inc receives notice of allowance for us looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search dr yutaka niihara  hematology  oncology specialist in torrance ca home doctors california torrance yutaka niihara doctors in torrance ca share on  yutaka niihara share on  medicare hematology  oncology specialist in torrance ca dr yutaka niihara is a hematology  oncology specialist in torrance california he graduated with honors from loma linda university school of medicine in  having more than  years of diverse experiences especially in hematologyoncology internal medicine dr yutaka niihara affiliates with county of los angeles auditor controller and cooperates with other doctors and specialists without joining any medical groups call dr yutaka niihara on phone number   for more information and advises or to book an appointment  normandie ave ste  torrance ca        map and directions doctor profile basics full name yutaka niihara gender male pecos id  experience  years of diverse experiences sole proprietor no  he does not own any unincorporated business by himself accepts medicare assignment he does accept the payment amount medicare approves and not to bill you for more than the medicare deductible and coinsurance medical specialities hematologyoncologyinternal medicine credentials doctor of medicine md education  training dr yutaka niihara attended to loma linda university school of medicine and then graduated in  nppes information npi   enumeration date jun th  last update date jul th  request for update medical licenses dr yutaka niihara has been primarily specialised is hematology  oncology for over  years specializationlicense numberissued state internal medicine  hematology  oncology g california affiliated hospitals hospital name hospital type hospital ownership location lac  harborucla med center acute care hospitals government  local torrance california practice location  normandie ave ste  torrance california  phone  fax   office hoursmonday  friday  am   pmsaturday  sunday closed this doctor profile was extracted from the dataset publicized on oct nd  by the centers for medicare and medicaid services cms and from the corresponded npi record updated on jul th  on nppes website if you found out anything that is incorrect and want to change it please follow this update data guide related doctors and physicians please enable javascript to view the comments powered by disqus most viewed physicians donald w inadomi  earl st suite  erol m kosar  lomita blvd suite  alberta w samuelson  lomita blvd  shahina hakim  madison st suite  gary charles coleman  west carson street suite  claudia mazzei  w carson st nourit h korzennik  madison st suite c hossein samadi  w carson st nearby physicians chandra m manuelpillai  w carson street box  jong h kim  pacific coast hwy ste b jean k sun  hawthorne blvd suite b luke a conovaloff  torrance blvd em dept david z presser  lomita blvd maximo h nunez  w carson st harborucla medical center newly added physicians peter frank mastan  hawthorne blvd suite  hanmo gu  torrance blvd suite  raj odhav  w carson st   cristiane guberman de andrade  w carson st box  daena s watcha  w carson st hyang rim ko  torrance blvd × update request request to immediately synchronize profile npi  from nppes to healthcarepplcom close submit sections overview profile medical licenses affiliated hospitals practice location reviews doctors in torrance ca sections best doctors and other health care professionals in california torrance usa home doctors california torrance doctors in california doctors and other health care professionals in torrance ca healthcareppl is your most comprehensive directory of doctors and other healthcare professionals in torrance ca healthcareppl provides detailed information including personal overview history of education and training specialities practice locations affiliated hospitals and more of  medicarecertified and other providers list of doctors and other health care professionals in torrance ca the list contains  physicians aaron bradley parrish  years of experience primary speciality general surgery aaron c gladman  years of experience primary speciality emergency medicine aaron s hong md  years of experience credential doctor of medicine md primary speciality anesthesiology aarthi arasu  years of experience primary speciality endocrinology aashini k master  years of experience primary speciality hematology  oncology abraham g lin  years of experience primary speciality orthopedic surgery adabel lee  years of experience primary speciality clinical psychologist adah m duncan md  years of experience credential doctor of medicine md primary speciality diagnostic radiology adam babitts  years of experience primary speciality physical therapy adam j jonas  years of experience primary speciality pediatric medicine newly added physicians peter frank mastan  hawthorne blvd suite  hanmo gu  torrance blvd suite  raj odhav  w carson st   cristiane guberman de andrade  w carson st box  daena s watcha  w carson st hyang rim ko  torrance blvd other services other health care providers in torrance ca supplier home health nursing home hospital dialysis facility medical group go to page  first  previous           next  last  emmaus life sciences announces reappointment of dr yutaka niihara as ce emmaus medical inc  torrance california  nutrestore zorbtive aminopure  treatments for short bowel and sickle cell disease overview mission leadership management team board of directors corporate compliance corporate governance products nutrestore pipeline cell sheet engineering sickle cell disease more information bibliography review articles for patients sickle cell disease short bowel syndrome news press releases media contacts investors career contact us press releases emmaus life sciences announces reappointment of dr yutaka niihara as ceo  continues to lead efforts to advance sickle cell disease treatment torrance calif january   – emmaus life sciences inc the company or emmaus a biopharmaceutical company engaged in the discovery development and commercialization of innovative treatments and therapies for rare and orphan diseases announced the recent reappointment of yutaka niihara md mph the company’s cofounder and chairman as ceo of the company  niihara will continue to lead the work on emmaus’ pharmaceutical grade lglutamine treatment pglg having completed its phase  trial for the management of sickle cell disease scd   “we started  with renewed focus continuing to advance our work on our sickle cell program” said niihara “in  we raised over  million with the support of loyal shareholders to bring our total funds raised to more than  million i would like to thank our loyal shareholders now in excess of  and express gratitude to our management team and new board members as we move forward” niihara is the principal inventor of the patented lglutamine therapy for treatment of sickle cell disease has been involved in patient care and research for sickle cell disease during most of his career and is a widely published author in the area of sickle cell disease dr niihara is boardcertified by the american board of internal medicinemedical oncology and the american board of internal medicinehematology he is licensed to practice medicine in both the us and japan dr niihara is a professor of medicine at the david geffen school of medicine at ucla he received his ba in religion from loma linda university in  and obtained his md degree from the loma linda university school of medicine in  and received his mph from harvard school of public health in  about emmaus life sciences emmaus life sciences is engaged in the discovery development and commercialization of innovative treatments and therapies for rare diseases the company’s research on scd was initiated by dr niihara at the los angeles biomedical research institute at harborucla medical center emmaus’ scd therapy has orphan drug designation in the us and europe and fast track designation from the fda the company has completed a  patient phase  trial for more information please visit wwwemmauslifesciencescom about sickle cell disease scd is an inherited blood disorder characterized by the production of an altered form of hemoglobin which polymerizes and becomes fıbrous causing red blood cells to become rigid and change form so that they appear sickle shaped instead of soft and rounded patients with scd suffer from debilitating episodes of sickle cell crisis which occur when the rigid adhesive and inflexible red blood cells occlude blood vessels sickle cell crisis causes excruciating pain as a result of insufficient oxygen being delivered to tissue referred to as tissue ischemia and inflammation these events may lead to organ damage stroke pulmonary complications skin ulceration infection and a variety of other adverse outcomes scd is an orphan disease in the us affecting approximately  patients in the us and millions worldwide with significant unmet medical needs  forwardlooking statements this press release contains forwardlooking statements as that term is defined in the private securities litigation reform act of  regarding the research development and potential commercialization of pharmaceutical products such forwardlooking statements are based on current expectations and involve inherent risks and uncertainties including factors that could delay divert or change any of them and could cause actual outcomes and results to differ materially from current expectations additional risks and uncertainties are described in reports filed by emmaus life sciences inc with the us securities and exchange commission including its annual report on form k and quarterly reports on form q emmaus is providing this information as of the date of this press release and does not undertake any obligation to update any forwardlooking statements as a result of new information future events or otherwise contacts media lori teranishi  lteranishiiqinccom    investors matt sheldon  msheldonpondelcom news press releases media contacts emmaus medical inc registered ® emmaus medical inc torrance ca all rights reserved site by magellannet privacy terms of use contact emmaus medical inc  torrance california  nutrestore zorbtive aminopure  treatments for short bowel and sickle cell disease adding multimedia generex welcomes dr yutaka niihara md mph to its board of directorshomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoretry yahoo finance on firefox »yahoosearchsearchsign inus markets open in  hrs  minssp futures dow futures nasdaq futures adding multimedia generex welcomes dr yutaka niihara md mph to its board of directorsbusiness wirejanuary  reblogsharetweetsharedr yutaka niihara md mph chairman  chief executive officer of emmaus life sciences inc has joined the generex board of directors as its executive chairman photo business wire multimedia gallery urlmoremiramar fla  torontobusiness wiregenerex biotechnology corporation gnbt is pleased to announce that dr yutaka niihara md mph chairman  chief executive officer of emmaus life sciences inc wwwemmauslifesciencescom has joined the generex board of directors as its executive chairmanthis smart news release features multimedia view the full release here httpwwwbusinesswirecomnewshomeen generex previously announced a deal to acquire a controlling equity interest in emmaus the company filed a form k current report in respect of that acquisition with the us securities and exchange commission on january   emmaus is also an sec registrant its filings including audited financial information are publicly available at wwwsecgovdr niihara received his doctor of medicine md degree from loma linda university’s school of medicine in  he completed his internship and residency at kettering medical center followed by a hematologyoncology fellowship at harborucla medical center he received his master of public health mph degree from the harvard school of public health in  he serves as a clinical professor of medicine at the david geffen school of medicine at ucladr niihara is a fellow of the american college of physicians and a member of the american society of clinical oncology and the american society of hematology his board certifications include the national board of medical examiners the japanese medical board the american board of internal medicine and abimhematology he maintains hospital affiliations at harborucla medical center and the torrance memorial medical centerjoseph moscato generex president  chief executive officer commented “we are honored to have a physician scientist and executive of dr niihara’s comprehensive experience and noteworthy accomplishment join the generex team he is certain to play a pivotal role in the future successes of generexemmaus”“it is with great anticipation that i join the new and repurposed generex board” dr niihara said “i look forward to making substantial contributions from both scientific and business perspectives to the implementation of the company’s strategic plans”cautionary note regarding forwardlooking statementsthis release and oral statements made from time to time by generex representatives in respect of the same subject matter may contain forwardlooking statements within the meaning of the private securities litigation reform act of  these statements can be identified by introductory words such as expects plan believes will achieve anticipate would should subject to or words of similar meaning and by the fact that they do not relate strictly to historical or current facts forwardlooking statements frequently are used in discussing potential product applications potential collaborations product development activities clinical studies regulatory submissions and approvals and similar operating matters many factors may cause actual results to differ from forwardlooking statements including inaccurate assumptions and a broad variety of risks and uncertainties some of which are known and others of which are not known risks and uncertainties include those identified from time to time in the reports filed by generex with the securities and exchange commission which should be considered together with any forwardlooking statement no forwardlooking statement is a guarantee of future results or events and one should avoid placing undue reliance on such statements generex undertakes no obligation to update publicly any forwardlooking statements whether as a result of new information future events or otherwise generex claims the protection of the safe harbor for forwardlooking statements that is contained in the private securities litigation reform actview source version on businesswirecom httpwwwbusinesswirecomnewshomeenmultimedia availablehttpwwwbusinesswirecomnewshomeenreblogsharetweetsharerecently viewedyour list is emptywhat to read nextbannon convinced jeff sessions to endorse trump and sessions worried his career in the republican party might end because of itbusiness insiderdiscover it  out of  avg by k customersdiscover cardsponsoredjennifer lopez bikes around nyc with alex rodriguez theres no place like homeentertainment tonightadrian beltre ejected for hilarious antics in ondeck circlebig league stewmelania trump’s floral dress is one of her prettiest style choices yetus weeklyengineer finds pattern makes millions in stocksmoney morningsponsored“game of thrones” just teased the first meeting of dany and jon and omfghello giggleskristin beck transgender navy seal hero lets meet face to face and you tell me im not worthybusiness insiderhighest ranking retired transgender officer slams new plan i think trump is ‘being influenced by pence’business insiderwomen everywhere should carry this tiny devicesiren songsponsoredphil mickelson trashtalked jordan spieth at the open championship — and phil is going to have to eat his wordsbusiness insideramazon’s echo rivaled by xiaomi and facebook rptyahoo finance videowhy the worlds biggest search engine has to pay for traffic to its siteyahoo financezuckerberg wifes ambitious secret finally exposedunewzmesponsoredmccain slams trumps transgender military ban says its why major policy announcements should not be made via twitterbusiness insiderap exclusive boy scouts chief expected a fiery trump speechassociated pressus parents are pulling their children out of boy scouts over donald trumps drunk stepdad speechkashco you just cant take him anywherejoin the conversation  k yutaka niihara  emmaus life sciences inc  email ceo emmauslifesciencescom cfo login  day free trial emmaus life sciences inc emmauslifesciencescom  hawthorne blvd torrance ca  phone  fax  type private employees    revenue    million industry servicesother biz services sic code unavailable view employees it intelligence news currently hiring historical trends it intelligence no categories no products found helpful hint the inside view displays a list of technologies and products used internally at a company f i r e w a l l show all analytics ecommerce google analytics google analytics shows you the full customer picture across ads and videos websites and social tools tablets and smartphones that makes it easier to serve your current customers and win new ones aspdotnetstorefront no description available sign up to see all helpful hint the outside view displays all the technologies and devices which can be seen on the internet news and background news and background company in the news january    new hire nametitleyutaka niihara chief executive officerexecutive chairman read entire article sign up to see all press events background full company description is available with the free trial name email address department get data willis lee title coo free trial for email operations export lan tran title chief administrative officer corporate secretary free trial for email administration export charles stark title svp research and development free trial for email research  development export yutaka niihara title chief executive officerexecutive chairman free trial for email executive export yasushi nagasaki title svp finance free trial for email finance export peter ludlum title copresident and chief business officer free trial for email executive export showing  to  of  entries level and organization level and organization historical trends historical trends yearly quarterly weekly quarterly poll question date created current result votes only for logged in user additional info emmaus life sciences inc a business led by ceo yutaka niihara is part of the other biz services industry emmaus life sciences inc email with the emmauslifesciencescom format you can check their lead profile they hold their main office in torrance ca and more data like cfo contacts and linkedin data can be found within our profiles if you sign up for our free trial you will see our emailemmauslifesciencescom addresses company background full company description is available with the free trial ceo reference yutaka niihara have you been looking for contact information like phone numbers and emails on yutaka niihara lead provides data on him which include twitter linkedin url wiki and biography there is also emmaus life sciences inc email addresses within the emmauslifesciencescom profile so yutaka niiharas email could be included yutaka niihara is part of the emmaus life sciences inc which has its main offices in torrance ca currently holds the post of chief executive officerexecutive chairman you can find the company data on lead under the other biz services industry some possible email formats for yutaka niihara are yniiharaemmauslifesciencescom yutakaniiharaemmauslifesciencescom yutakaemmauslifesciencescom and yutakaniiharaemmauslifesciencescom if you sign up for our free trial you will see our emailemmauslifesciencescom addresses similar companies keymedia this member of the other biz services industry is located in foster city ca and you can find important contact information regarding significant company contacts on their lead profile like linkedin phone numbers facebook and cfo details the profile also contains keymedia email addresses which have a domain of keymediacom format if you sign up for our free trial you will see our emailkeymediacom addresses neo life neo life a other biz services company is based in fremont ca they can be reached through neo life email format addresses indicated on their lead profile with a domain of gnldcom if you sign up for our free trial you will see our emailgnldcom addresses j d heiskell  company j d heiskell  company is in the other biz services industry their main office can be found in tulare ca and they can be contacted through j d heiskell  company email using the domain heiskellcom format some important contact information like linkedin data phone numbers contacts for cfos etc of which can be found on their lead profile if you sign up for our free trial you will see our emailheiskellcom addresses company directory  emmaus life sciences inc unavailable  fidelity investments skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window stock research  ideas stock research center my research screen  filter stock screeners preset expert strategies news  insights events calendar upgrades  downgrades explore firm research research firms research firm scorecards reports search related resources fidelity learning center us markets global markets sectors  industries this feature is temporarily unavailable copyright – fmr llc  all rights reserved  terms of use privacy security site map  stock market research top stocks quotes  news  fidelity investments skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window stock research  ideas you are here stock research center my research screen  filter stock screeners preset expert strategies news  insights events calendar upgrades  downgrades explore firm research research firms research firm scorecards reports search related resources fidelity learning center us markets global markets sectors  industries stock research center not a fidelity customer no problem try our research for free without opening an account   trending stocks market movers top rated by sector orders by fidelity customers filters refresh equity summary score provided by starmine investing insights technical events provided by recognia as of  methodology recognia methodology bullish and bearish events of the day provide longshort trading ideas by identifying us stocks that have recently formed a bullish or bearish classic chart pattern patterns must have taken at least  days to form which draws out the more significant patterns for intermediate or longterm trend direction the list is then filtered to include stocks with a minimum  for bullish and  for bearish close price and a minimum  trading volume most recent patterns are listed first patterns on the same date are sorted using recognias proprietary quantitative algorithm to draw strong companies to the top and if further sorting is required for stocks with the same quantitative analysis result it is done by trading volume to draw highest volume stocks to the top ibp log in for events bku ncs ebsb amd derm log in for events lxu lxu inn gd find out how to use fundamental analysis and technical analysis when evaluating stocks with the help of the fidelity learning center my research –  organize and track your favorite securities get started todays events as of  am et  earnings  dividends  splits  upgrades  downgrades  economic  upcoming webinar events visit the learning center events page for a full list of upcoming webinars the equity summary score is provided for informational purposes only does not constitute advice or guidance and is not an endorsement or recommendation for any particular security or trading strategy the equity summary score is provided by thomson reuters starmine an independent company not affiliated with fidelity investmentsgics® global industry classification standards is an industry classification system developed by standard  poors in collaboration with morgan stanley capital international msci sp uses gics to determine the market segment to which a company is assignednews commentary including related symbols and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their usestock markets especially foreign markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments sector funds can be more volatile because of their narrow concentration in a specific industrysystem availability and response times may be subject to market conditionsthe fidelity screeners are research tools provided to help selfdirected investors evaluate securities the criteria and inputs entered are at the sole discretion of the user and all screens or strategies with preselected criteria are solely for the convenience of the user information supplied or obtained from the screeners is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell securities or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy or approach to screening or evaluating stocks preferred securities exchange traded products or closed end funds fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their use determine which securities are right for you based on your investment objectives risk tolerance financial situation and other individual factors and reevaluate them on a periodic basis copyright – fmr llc  all rights reserved  terms of use privacy security site map  gnbt stock news  fidelity skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print  helpglossary helpglossary news  eventsgnbt generex biotechnology corporation    as of pm et  quotes delayed at least  min log in for real time quote add to watch list set alert hypothetical trade price history download to csv file download to excel file log in for more news expand all collapse all gnbt currently has no news todays and upcoming events no events in the next  days past events last  days no events in the past  days data provided by wall street horizon inc   technical events classic patterns past  days provided by recognia inc log in for trading events view all technical analysis in advanced chart technical analysis provided by trading central log in for trading events as with all your investments through fidelity you must make your own determination whether an investment is appropriate for you fidelity is not recommending or endorsing this security by making it available to customers you should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase before investing you should read the prospectus offering circular indenture or similar document carefully for a full description of the product including its features and risks to determine whether it is an appropriate investment for your investment objectives risk tolerance financial situation and other individual factors and be sure to reevaluate those factors on a periodic basisperformance data shown represents past performance which is no guarantee of future results current performance may be higher or lower than the performance data quoted yield and return will vary therefore you may have a gain or loss when you sell your sharesstock markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments growth stocks can be more volatile than other types of stocks value stocks can continue to be undervalued by the market for long periods of time foreign securities are subject to interestrate currencyexchangerate economic and political risks all of which are magnified in emerging markets illiquidity is an inherent risk associated with investing in real estate and reits there is no guarantee the issuer of a reit will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid closedend funds can trade at a discount to their nav shareholders of master limited partnerships may be treated as partners for tax purposes partnerships issue a schedule k form  rather than a form  form for tax purposes it lists the partners share of income deductions credits etc speak with your tax advisor to determine how this may affect you a royalty trust is a type of corporation mostly in the united states or canada usually involved in oil and gas production or mining royalty trusts may have special tax treatment so you should consult a tax advisor on the potential tax consequences of investing in themnews commentary and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their useany data charts and other information provided on this page are intended for research purposes to help selfdirected investors evaluate many types of securities including but not limited to common stocks american depository receipts master limited partnerships real estate investment trusts traditional preferred stock trust preferred securities thirdparty trust certificates convertible securities mandatory convertible securities and other exchangetraded equity andor debt securities criteria and inputs entered including the choice to make security comparisons are at the sole discretion of the user and are solely for the convenience of the user analyst opinions ratings and reports are provided by thirdparties unaffiliated with fidelity all information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell a security or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy any analyst opinionratingreport or any approach to evaluating individual securities fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from its use copyright – fmr llc  all rights reserved  terms of use privacy security site map  see the latest features personalizedget relevant information about your holdings right when you need itsee your performance click the portfolio icon to get information about stocks you own without leaving the research pagefaster access to positions a shortcut to view the full list of positions in your portfolio yes please use the ticker search boxadd your own notes use notebook to save your investment ideas in one convenient private and secure place convenient for youresearch thats clear accessible and all in one place makes for a better experienceonestop shop see everything you need to make investment decisions right in the dashboardaccess anywhere no matter where you are use the stock research experience across multiple devicesnew ideas on the ready find new ideas using quick links to the stock screener new ways to researchdiscover new tools to add or diversify your existing research strategystocktwits read live tweets from the financial and investing community about the stock youre interested infundamental analysis save time on research by getting an overall assessment of a companys valuation quality growth stability and financial healthrecognia technical analysis perfect for the technical trader—this indicator captures a stocks technical events and converts them into short medium and longterm sentimenttop competitors see how a stock measures up by instantly comparing it to the industry average and its top four competitorssocial sentiment get a sense of peoples overall feelings towards a company in social media with this summary toolearnings data monitor earnings expectations over the past three quarters and model a stocks price based on its pe microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft yutaka niihara  wowcom  web results aol search skip over navigation search the web web images images reference reference yutaka niihara  vitalscom ad · vitalscom​dryutaka niihara find yutaka niihara online free report address  phone number we found yutaka niihara  cell phone  address pics  more ad · wwwspokeocom​yutaka niihara cell phone  address pics  more yutaka niiharas info  look free free people search search public records white pages directory social network search dr reviews  ucomparehealthcarecom ad · ucomparehealthcarecom​reviews phone number locations ratings reviews  compare searches related toyutaka niihara dr yutaka niihara web results dr yutaka niihara md  torrance ca  oncology  wwwhealthgradescomphysiciandryutakaniiharaynxr visit healthgrades for information on dr yutaka niihara md find phone  address information medical practice history affiliated hospitals and more yutaka niihara  professional profile httpswwwlinkedincominyutakaniiharaa view yutaka niihara’s professional profile on linkedin linkedin is the worlds largest business network helping professionals like yutaka niihara discover inside  dr yutaka niihara hematologist in torrance ca  us news  healthusnewscomdoctorsyutakaniihara dr yutaka niihara is a hematologist in torrance ca find dr niiharas phone number address insurance information hospital affiliations and more yutaka niihara md mph executive profile  biography  httpswwwbloombergcomresearchstocksprivatepersonasp dr yutaka niihara md mph has been the chief executive officer of emmaus life sciences inc since january  and served as its chief scientific  dr yutaka niihara md – torrance ca  hematology httpswwwdoximitycompubyutakaniiharamd dr yutaka niihara md is a hematologist in torrance california he is affiliated with harborucla medical center torrance memorial medical … yutaka niihara md mph  la biomed httpslabiomedorgyutakaniiharamdmph research description dr niihara has been involved in patient care and research for sickle cell disease for most of his career and is the principal inventor of the  adding multimedia generex welcomes dr yutaka niihara md  httpsfinanceyahoocomnewsgenerexwelcomesdryutakaniihara generex biotechnology corporation is pleased to announce that dr yutaka niihara md mph chairman  chief executive officer of emmaus life sciences inc  has  yutaka niihara md mph ceo of emmaus appointed  wwwprnewswirecomnewsreleasesyutakaniiharamdmphceoof yutaka niihara md mph ceo of emmaus appointed executive chairman of generex biotechnology  niihara md yutakaniihara  twitter httpstwittercomyutakaniihara the latest tweets from  niihara md yutakaniihara 「 … yutaka niihara md mph ceo of emmaus appointed  httpsfinanceyahoocomnewsyutakaniiharamdmphceo torrance calif jan   prnewswire  emmaus announced today that its chairman and chief executive officer yutaka niihara md mph has joined the board of  yutaka niihara  vitalscom ad · vitalscom​dryutaka niihara find yutaka niihara online free report address  phone number we found yutaka niihara  cell phone  address pics  more ad · wwwspokeocom​yutaka niihara cell phone  address pics  more yutaka niiharas info  look free free people search search public records white pages directory social network search dr reviews  ucomparehealthcarecom ad · ucomparehealthcarecom​reviews phone number locations ratings reviews  compare searches related toyutaka niihara dr yutaka niihara next search the web  aol inc all rights reservedprivacy   terms of use   about our ads   preferences   contact us   powered by bing™ part of the aol search network dr yutaka niihara md  torrance ca  oncologist professionals doctorsttcqeayetrwczwezdueawsrsbdyr dentists podiatrists chiropractors optometrists facilities pharmacies nursing homes urgent care hospitals group practices patient education care guides well informed center corporate about us smartshopper vitalschoice advertise with us careers find location menu dr yutaka niihara md phone number read reviews advertisement advertisement advertisement dr yutaka niihara is this you update your information here the vitals website is provided for your informational use only nothing contained or offered by on or through vitals should be construed as medical advice or relied upon for medical diagnosis or treatment vitals does not recommend or endorse any particular healthcare provider whose information or ratings appear on this website we encourage you to read our full terms of service advertisement dr yutaka niihara md hematology and oncology torrance ca read reviews phone number summary patient reviews locations  directions insurances credentials patient reviews reviews reflect patients level of satisfaction with the care they received from this provider dr yutaka niihara xhas an overall rating of    patient ratings comment have you seen dr yutaka niihara before write a review read reviews about dr yutaka niihara md is a doctor primarily located in torrance ca he has  years of experience his specialties include hematology and oncology internal medicine hematology and medical oncology dr niihara is affiliated with providence little co of mary medical center san pedro childrens hospital los angeles and providence little co of mary medical center torrance he speaks english  language find out the languages this doctor or staff may speak view all  education learn where this doctor attended medical school view all advertisement specialties  expertisedr yutaka niihara has the following  areas of expertise  specialties and  board certifications  specialties for the best health care select a doctor who specializes in your medical condition view all  expertise see areas of expertise for treating specific conditions procedures and surgeries for this doctor view all  board certifications see the board certifications this doctor has received board certifications provide confidence that this doctor meets the nationally recognized standards for education knowledge and experience view all advertisement health guides metastatic melanoma the facts about metastatic melanoma a serious skin cancer including signs symptoms  what happens to the body in each stage of cancer view care guide more health guides birth control lung cancer skin cancer type  diabetes breast cancer cancer chemotherapy copd flu locations  directions lacharborucla medical center  w carson st torrance ca  phone number get directions nearby doctors dr yutaka niihara md is similar to these  doctors near torrance ca dr loren miller torrance ca  view profile dr wael salameh torrance ca  view profile dr david yuchno torrance ca   years experience view profile advertisement advertisement have you visited dr yutaka niihara share your experience by clicking a star above i agree to the terms of use and verify that i have received treatment from this doctor i havent visited this doctor yet continue home  find an oncologist  ca  torrance oncologists  dr yutaka niihara md advertisement